QUEST DIAGNOSTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136.5 USD | +4.95% |
|
+7.15% | -0.98% |
| 03:05pm | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
| 02:30pm | Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
06:45am
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
130.1
USD
Average target price
142.3
USD
Spread / Average Target
+9.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.98% | 14.45B | |
| -12.69% | 87.77B | |
| +17.99% | 82.08B | |
| +11.97% | 30.03B | |
| -8.54% | 17.08B | |
| -1.46% | 16.41B | |
| +4.44% | 12.37B | |
| +5.11% | 12.17B | |
| -31.05% | 11.89B | |
| +27.98% | 11.62B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- UBS Adjusts Quest Diagnostics Price Target to $147 From $140, Maintains Neutral Rating
